Detalhe da pesquisa
1.
Beyond COVID-19 and lessons learned in the United States.
Transfus Med
; 33(1): 6-15, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918741
2.
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
Clin Infect Dis
; 74(5): 871-881, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111244
3.
Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
J Infect Dis
; 223(5): 743-751, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417696
4.
Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
Transfusion
; 61(8): 2374-2383, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904609
5.
Minipool testing for SARS-CoV-2 RNA in United States blood donors.
Transfusion
; 61(8): 2384-2391, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046906
6.
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2.
Transfusion
; 61(1): 78-93, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125158
7.
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
JAMA
; 326(14): 1400-1409, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473201
8.
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
J Clin Microbiol
; 58(12)2020 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917729
9.
How did we rapidly implement a convalescent plasma program?
Transfusion
; 60(7): 1348-1355, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449169
10.
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.
Proc Natl Acad Sci U S A
; 111(44): 15798-803, 2014 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331901
11.
Perception of low-titer group A plasma and potential barriers to using this product: A blood center's experience serving community and academic hospitals.
Transfus Apher Sci
; 55(1): 141-5, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27344482
12.
How do I provide leukapheresis products? Blood center experience and evidence for process improvement.
Transfusion
; 53(10): 2123-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23113726
13.
West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.
Transfusion
; 52(12): 2664-70, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22486471
14.
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
medRxiv
; 2020 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577675
15.
Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions.
Blood Adv
; 1(15): 1142-1147, 2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296756
16.
Prenatal exposure to bisphenol A and phthalates and infant neurobehavior.
Neurotoxicol Teratol
; 33(5): 558-66, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854843